HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,188,392 | +7.7% | 347,380 | -4.2% | 0.06% | +17.0% |
| Q2 2023 | $37,303,386 | -6.7% | 362,697 | -1.0% | 0.05% | -10.2% |
| Q1 2023 | $39,971,979 | -3.8% | 366,245 | +0.3% | 0.06% | -9.2% |
| Q4 2022 | $41,565,791 | +86.7% | 365,253 | +1.5% | 0.06% | +71.1% |
| Q3 2022 | $22,264,000 | -24.6% | 359,734 | -2.8% | 0.04% | -19.1% |
| Q2 2022 | $29,532,000 | -23.6% | 370,262 | +0.8% | 0.05% | -7.8% |
| Q1 2022 | $38,660,000 | -7.7% | 367,451 | -5.5% | 0.05% | +4.1% |
| Q4 2021 | $41,903,000 | -0.2% | 388,851 | +1.4% | 0.05% | -9.3% |
| Q3 2021 | $42,002,000 | +16.8% | 383,444 | -0.1% | 0.05% | +20.0% |
| Q2 2021 | $35,947,000 | +2.1% | 383,890 | +0.4% | 0.04% | -4.3% |
| Q1 2021 | $35,202,000 | +27.5% | 382,460 | +1.3% | 0.05% | +20.5% |
| Q4 2020 | $27,607,000 | +3.5% | 377,408 | +9.9% | 0.04% | -9.3% |
| Q3 2020 | $26,669,000 | +52.0% | 343,320 | +8.7% | 0.04% | +38.7% |
| Q2 2020 | $17,547,000 | +90.9% | 315,706 | +1.7% | 0.03% | +55.0% |
| Q1 2020 | $9,194,000 | -13.0% | 310,390 | +6.3% | 0.02% | +11.1% |
| Q4 2019 | $10,569,000 | +32.5% | 291,958 | -0.3% | 0.02% | +12.5% |
| Q3 2019 | $7,976,000 | +13.6% | 292,915 | +0.4% | 0.02% | +14.3% |
| Q2 2019 | $7,021,000 | – | 291,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |